secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2023-03-23T23:59:59+00:00
Accession:  0001493152-23-008636
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus appoints Walt Linscott as COO; sets 2023 annual meeting for May 25
---------------------------------------------------------------------------

- Walt Linscott, previously Chief Business Officer, appointed COO effective March 22, 2023.
- Robert Martell, M.D., Ph.D. appointed to Board's Science and Technology Committee.
- Annual meeting set for May 25, 2023; stockholder proposals due by April 2, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000149315223008636/0001493152-23-008636-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000149315223008636/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-008636

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer